Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Castration Video"

08:22 EDT 19th April 2014 | BioPortfolio

Matching Channels

Video capsule endoscopy

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

PolyXen

PolyXen® is an enabling technology for protein drug delivery.  It uses the natural polymer polysialic acid (PSA) to prolong the active life and improve the stability of therapeutic peptides...

ImuXen

ImuXen® is a liposomal technology platform designed to improve the delivery and effectiveness of DNA, protein and polysaccharide vaccines. Proof of concept preclinical studies with a number of...

Matching News

The hidden world of self-castration and testicular self-injury

Johnson and Irwig discuss a community of biological males who desire emasculation and commonly resort to self-castration, castration by nonmedical professionals, or self-inflicted testicular damage vi...

[Comment] Anti-androgen monotherapy for metastatic prostate cancer

Prostate cancer is commonly an androgen-driven disease, and for several decades the mainstay of first-line treatment for metastatic disease has been medical or surgical castration to suppress gonadal...

No Benefit to Earlier Use of Bone Drug in Prostate Cancer

Use of zoledronic acid for castration-sensitive prostate cancer does not decrease the risk for skeletal events, compared with treatment started after progression to castration-resistant disease. Med...

Optimizing patient outcomes in metastatic castration-resistant prostate cancer (mCRPC)

Dr Fizazi introduces this symposium that assesses the way in which treatment options should be applied to patients with castration-resistant prostate cancer. Within the last 4 years, substantial adva...

Post-Docetaxel in Castration-Resistant Prostate Cancer

Castration-resistant prostate cancer patients previously treated with docetaxel can benefit from current available therapies -- even those with poor performance status. Prostate Cancer and Prostatic...

Maximizing survival in metastatic Castration-Resistant Prostate Cancer (mCRPC)

Within the last 4 years, the prognosis of metastatic castration-resistant prostate cancer (mCRPC) has dramatically changed with 5 novel therapies demonstrating a survival benefit in phase III clinical...

ASCO GU: Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

Results from the phase III PREVAIL study show that the androgen-receptor blocker enzalutamide increases survival by 29 percent in men with metastatic castration-resistant prostate cancer (mCRPC) and d...

Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant prostate cancer

Recently, a number of therapies have been approved that provide more treatment options and improve outcomes for men with metastatic castration-resistant prostate cancer (mCRPC). This expert discussion...

Matching PubMed Articles

Video microscopy, video cameras, and image enhancement.

Video microscopy is the application of video technology to microscopy, resulting in two fields of microscopy called video-enhanced contrast microscopy (VEC) and video-intensified microscopy (VIM). VEC...

Video Traffic Characteristics of Modern Encoding Standards: H.264/AVC with SVC and MVC Extensions and H.265/HEVC.

Video encoding for multimedia services over communication networks has significantly advanced in recent years with the development of the highly efficient and flexible H.264/AVC video coding standard...

Preoperative ketoprofen administration to piglets undergoing castration does not affect subsequent growth performance.

The purpose of this study was to determine if treatment of pigs with ketoprofen (3 mg/kg body weight) before castration at 7 days of age would affect subsequent growth during the suckling period. Pigl...

Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.

Previously, we have shown that Y-box binding protein-1 (YB-1) regulates androgen receptor (AR) expression and contributes to castration resistance. However, the mechanism of YB-1 activation remains un...

Inhibition of Protein Kinase C / Twist1 Signaling Augments Anti-Cancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer.

The progression of prostate cancer to metastatic and castration-resistant disease represents a critical step. We previously showed that the transcription factor Twist1, which promotes epithelial-mesen...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement